Enovix Corp (ENVX)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Enovix Corp.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 4.10 $ — 4% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 72.5% passed
- More than 10% revenue growth is expected for the coming year 125.2% passed
- Share count grows by less than 3% a year 10.4% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -318.8% failed
- Gross margin at 40% or higher and without meaningful erosion -86.8% failed
- Goodwill from acquisitions does not grow faster than revenue 1.4% passed
- Net debt below twice EBITDA failed
- Operating cash flow covers the profits of the last three years 225 m failed
- Return on capital at 15% or higher, or up versus two years ago -21.7% failed
- Insiders hold at least 10% or are net buyers 11.4% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 215.9% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 13
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.57 | -0.63 – -0.52 | 41 | -4.6% | 9 |
| 12/31/2027 | -0.57 | -1.03 – -0.14 | 91 | -1.3% | 9 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.20 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.20 | – | 10 | 31.60 | -385.60 | -16 | -32 |
| 2025: Q1 | -0.12 | – | 5 | -3.30 | -461.20 | -17 | -23 |
| 2025: Q2 | -0.22 | – | 8 | 98.20 | -596.30 | -26 | -34 |
| 2025: Q3 | -0.26 | – | 8 | 85.10 | -672.30 | -26 | -29 |
| 2025: Q4 | -0.17 | – | 11 | 15.90 | -310.60 | -27 | -28 |
| 2026: Q1 | -0.18 | – | 8 | 49.10 | -503.40 | -33 | -36 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | – | -17 | -16 | -0.28 | -11 | 4 | 17 |
| 2020 | 0 | -24 | -40 | -0.27 | -20 | 36 | 65 |
| 2021 | 0 | -70 | -126 | -1.07 | -52 | 326 | 483 |
| 2022 | 6 | -127 | -52 | -0.33 | -83 | 356 | 441 |
| 2023 | 0 | -165 | -154 | -0.97 | -105 | 258 | 564 |
| 2024 | 23 | -243 | -222 | -1.27 | -109 | 247 | 527 |
| 2025 | 32 | -177 | -157 | -0.75 | -95 | 271 | 880 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Enovix Corporation entwirft, entwickelt und fertigt Lithium-Ionen-Batteriezellen in den USA und international. Es bedient die Bereiche Wearables und IoT, Smartphones, Computer, Elektrofahrzeuge und Erstausrüster.
| Employees | 664 |
|---|---|
| Headquarters | Fremont, CA |
| Address | 3501 West Warren Avenue, 94538 Fremont, United States |
| Phone | 510 695 2350 |
| Website | enovix.com |
| IPO Date | 15. Jul 2021 |
| ISIN | US2935941078 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Raj Talluri Ph.D. | President, CEO & Director | 1963 |
| Ryan A. Benton | Chief Financial Officer | 1971 |
| Arthi Chakravarthy | Chief Legal Officer, General Counsel, Secretary & Head of Corporate Development | 1979 |
| Robert M. Spotnitz | Founder | – |
| Kristina Truong | Senior VP & Chief Accounting Officer | – |
| Hongwei Yan | Chief Technology Officer | – |
| Robert Lahey | Head of Investor Relations | – |
| Steven R. Bakos | Senior Vice President of Worldwide Sales | 1967 |
| Iryna Romaniv | Chief Human Resources Officer | – |
| James Wilcox Ph.D. | VP of Business Development & Head of Enovix Mobility | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 24. Jul 2026 | Chakravarthy Arthi | Chief Legal Officer | Other | 2,221 | 3.95 | 8,773 |
| 18. Jul 2026 | Talluri Rajendra K | President and CEO | Other | 17,651 | 4.72 | 83,313 |
| 14. Jul 2026 | Benton Ryan A | Chief Financial Officer | Other | 19,824 | 5.06 | 100,309 |
| 13. Jul 2026 | Truong Kristina | Chief Accounting Officer | Other | 1,015 | 4.95 | 5,024 |
| 10. Jul 2026 | Truong Kristina | Chief Accounting Officer | Other | 253 | 5.20 | 1,316 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.